Expanding the MECP2 network using comparative genomics reveals potential therapeutic targets for Rett syndrome
Sign Up to like & getrecommendations! Published in 2021 at "eLife"
DOI: 10.7554/elife.67085
Abstract: Inactivating mutations in the Methyl-CpG Binding Protein 2 (MECP2) gene are the main cause of Rett syndrome (RTT). Despite extensive research into MECP2 function, no treatments for RTT are currently available. Here, we used an… read more here.
Keywords: comparative genomics; expanding mecp2; rett syndrome; mecp2 ... See more keywords